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Objectives: Heart Failure (HF) is themajor cause of hospitalization
in the US but the molecular mechanisms underlying its development
are unclear to date. The increased formation of preamyloid oligomers
(PAOs), similar to those observed in Alzheimer's disease, have been
reported in several different models of HF. We first reported that
the induction of desmin phosphorylation at serines (S) 27 and 31
associate with increased cardiac PAOs deposition in experimental,
non-genetic HF. We now show that modified desmin is a likely
candidate for the seed initiating the nucleation of toxic PAOs in the
heart and isolated cardiac cells.
Materials and methods: We subjected mice to transverse aortic
constriction (TAC) for 4 weeks (FS% = 29.3 ± 2.6, P = 0.0001) and
transduced neonatal rat ventricular myocytes (NRVMs) using lentiviral
vectors carrying alanine (A) or phospho-mimetic aspartate (D) desmin
double mutants at S27 and S31, fused with GFP. We analyzed the
formation of PAOs in cardiac protein extracts by western blot analysis
combined with infrared detection, which enabled the contemporary
measurement of PAOs and desmin. We also monitored the effects of
phospho-mimetic desmin expression in NRVMs by live imaging.
Results: Co-staining for both desmin and PAOs in TAC mice and
NRVMs confirmed the co-migration (by molecular weight) of PAOs
with modified desmin, along with their increase in experimental HF
(≈3-fold, P = 0.023 and≈ 2-fold, P = 0.038, respectively). Cells
expressing the doubly phospho-mimetic mutant, which we believe is
the physiological form, displayed a “healthier” phenotype as docu-
mented by the number of contracting cells (P = 0.041) and localiza-
tion of GFP desmin at the Z-bands (P = 0.0027). On the contrary the
expression of mono-phosphomimetic mutant (S27A, S31D) induced
increased desmin aggregation (P = 0.0014).
Conclusions: These data strongly suggest that modified desmin
constitutes the seed initiating the formation of cardiac PAOs in non-
genetic HF. The increased levels of toxic desmin PAOs in the heart
could, therefore, represent a novel mechanism of organ dysfunction
in HF, in the absence of genetic mutations.
doi:10.1016/j.vph.2015.11.003
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Objectives: Catestatin (CST), a 21-amino acid derivate of
Chromogranin A, exerts several biological functions, including inhibition
of catecholamine release and cardioprotective role. Moreover positive
effect of CST on monocyte migration in vitro and the induction of
angiogenesis, arteriogenesis and vasculogenesis in the mouse hind limb
ischemiamodel have been demonstrated. Collateral arteriesmay provide
a biological bypass for occluded atherosclerotic vessels, increasing blood
flow to ischemic tissue. In such a prospective, CST is a very promising
agent for revascularization purposes, in “NO-OPTION” patients. How-
ever, proteins have a very short half-life after administration and must
be conveniently protected. FN-PAMs, biodegradable and biocompatible
polymeric microspheres, have ideal characteristic for this purpose:
besides to convey peptides and allow in situ prolonged/controlled
delivery, they may also convey cells on their biomimetic surface and
may favor their survival and engraftment after cell transplantation. In
this study, we show that CST can be incorporated within FN-PAM and
aim to demonstrate that CST may be released in a slowly/prolonged
manner by FN-PAM. We also aim to demonstrate that CST released by
FN-PAM may reduce cell death under different stress conditions.
Materials and methods: CST has to be precipitated to ensure its
stability upon subsequent encapsulation. Protein precipitate is formed
from aqueous solution by the addition of a watermiscible organic
solvent. PLGA–P188–PLGA (triblock) copolymeric microspheres
are prepared using solid/oil/water emulsion solvent evaporation–
extraction technique. PAMs are coated with Fibronectin and char-
acterized by Immunofluroscence (confocal microscopy). Mesenchy-
mal stem cells (MSC) are exposed to hypoxia (72 h in 1–2%O2) and
reoxygenation (6 h in 21% O2) in a hypoxic chamber with or without
CTS, FN-PAMs or CTS-FN-PAMs. The protective effects of treatments
are detected by MTT assay.
Results: To define the optimum condition of nanoprecipitation we
used an experimental design, modifying parameters influencing
protein precipitation: ionic strength, mixing and centrifugation time.
Nanoprecipitation of CST was found to be 72%. Controlled release of
CST from CTS-FNPAM greatly limits hypoxic MSC death and enhances
MSC survival in post-hypoxic environment.
Conclusions: FN-PAMs are successfully formulated with CST.
By an experimental design, we found optimal conditions to obtain a
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good CTS nanoprecipitation yield. MSC readily adhere to the FN-PAM
and CST-FN-PAMs reduce MSC death enhancing survival in post-
hypoxic environment. Data suggest that CST-FN-PAMs are promising
tools for therapeutic purpose.
doi:10.1016/j.vph.2015.11.004
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Objectives: The link between endothelial shear stress (SS)
patterns and localization of atherosclerotic plaques is well
established. The atherosclerotic lesions form in specific regions of
the arterial tree characterized by oscillatory SS (OSS), while regions
exposed to laminar SS (LSS) are not susceptible to plaques onset. In
vitro and in vivo studies have shown that endothelial cells subjected
to OSS are predisposed to apoptosis and other dysfunctions, events
that underlie plaques formation. The Notch pathway modulates
endothelial cells apoptosis and we demonstrated that several Notch
pathway components have lower expression levels in regions of mice
aorta subjected to OSS compared to LSS. Moreover, we have shown
that ivabradine, a heart rate reducing agent which may exert a
protective activity by modifying the OSS on the endothelium, induces
a less atherogenic gene expression profile in the endothelium of
aortic arch of ApoE-deficent mice and modulates the Notch pathway.
This study aims to better define the modulation of Notch signaling by
SS by using an ex vivo culture system (coneand-plate system).
Materials and methods: Human Umbilical Vein Endothelial Cells
(HUVECs) were exposed to LSS at 50 dyn/cm2 (200 rpm) by using
smooth cones to OSS at 12.5 dyn/cm2 (50 rpm) by using grooved
cones for 24 h. After 24 h, at least five random images were taken for
each 100-mm dish using a phase contrast microscope to monitor the
cells status. We measured mRNA levels of several Notch components
(Hey1, Hey2, Hes1, Notch1, Notch2, Notch4, Jagged-1 and Jagged-2)
and we also evaluated by immunofluorescence protein levels of
Notch receptors (Notch1 and Notch4).
Results: HUVECs exposed to LSS were elongated with the major
axis aligned in the direction of flow, whereas those exposed to OSS
were round in shape with a not well-defined axis direction, structures
that resemble those we found in regions of mice aorta exposed to
different SS patterns. A significant increase of many Notch compo-
nents (Hey1, Hey2, Notch1, Notch2 and Jagged-1) mRNAs levels was
obtained in HUVECs exposed to LSS compared to OSS. These data were
also supported by immunofluorescence analysis in which we found
that in OSS treated cells there was a reduction of Notch1 and Notch4
protein levels compared to LSS treated cells.
Conclusions: These data show a differential Notch regulation by
different SS conditions. It remains to be better established whether
downregulation of Notch signaling by OSS could be involved in
atherosclerotic plaques onset and/or progression.
doi:10.1016/j.vph.2015.11.005
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Objectives: Myostatin (Mstn) is a TGF-β family member involved
in skeletal muscle growth inhibition and heart fibrosis. Despite the
finding that loss of Mstn decreases atherosclerosis in LDL/-mice,
its role in vascular remodeling is still unknown. We sought to verify
whether Mstn is operative aortic wall deterioration during develop-
ment of atherosclerosis and abdominal aortic aneurysm (AAA).
Materials and methods: We first evaluated Mstn expression
in samples of human abdominal aorta with increasing severity of
atherosclerotic lesions, from healthy vessels up to AAA. Then, we
investigated the in vitro effects of Mstn on vascular smooth muscle
cell (VSMC) and monocyte biology.
Results: In aortic specimens, Mstn mRNA was dramatically
increased in AAA (N = 7) compared to healthy vessels (N = 4) or
early atherosclerotic lesions (N = 6) (p b 0.05); Mstn immunostain-
ing increased with the severity of the atherosclerotic lesion (normal
aortas, N = 4; late atherosclerotic lesions, N = 7; AAA, N = 9), was
associated to a reduced positivity for Smoothelin (Smtn), a protein
with contractile function in VSMCs (p b 0.05), and co-localized with
α-SMA and CD45 immunoreactivity, suggesting that Mstn is predom-
inantly expressed in VSMCs and leukocytes. Treatment of A7R5 VSMCs
with Mstn (500 ng/ml) modulated the gene expression of MCP-1 and
CCR2 (upregulated after 4 h) and of Smoothelin (downregulated after
48 h), increased the migratory rate and decreased the cell prolifera-
tion. In THP-1 monocytes, Mstn increased the MCP1-dependent
chemotaxis (p b 0.01). In PBMNCs, MCP-1 increased Mstn mRNA; in
turn, Mstn upregulated a-SMA and MCP-1 mRNA, caused overexpres-
sion and cortical distribution of-actin and acted as a chemoattractant
dose dependently, with the highest rate at 500 nM, indicating a
differentiation into an activated phenotype.
Conclusion: Mstn is overexpressed in atherosclerotic lesions and
AAAs at sites of leukocyte infiltration and phenotype-switching VSMCs.
Mstn causes loss of cell function in VSMCs and triggers a feed-forward
inflammatory loop leading to recruitment of fibroblast-like monocytes.
Therefore, Mstn sustains a chronic inflammatory milieu that elicits
activation of dystrophic events, resulting in aortic wall deterioration.
doi:10.1016/j.vph.2015.11.006
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Objectives: The perifollicular vasculature undergoes hair follicle
(HF) cycle dependent expansion and degeneration. Multiple soluble
factors derived from follicle dermal papilla cells (FDPCs) may act on
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